[1]
Z. Rani, B. Bashir, and I. Hussain, “Omalizumab: new addition to dermatologic therapy for chronic spontaneous/idiopathic urticaria”, J Pak Assoc Dermatol, vol. 25, no. 4, pp. 249–251, Nov. 2016.